Stem Point Capital LP Insmed Inc Transaction History
Stem Point Capital LP
- $378 Billion
- Q1 2024
A detailed history of Stem Point Capital LP transactions in Insmed Inc stock. As of the latest transaction made, Stem Point Capital LP holds 272,448 shares of INSM stock, worth $19.9 Million. This represents 1.95% of its overall portfolio holdings.
Number of Shares
272,448
Previous 173,579
56.96%
Holding current value
$19.9 Million
Previous $5.38 Billion
37.41%
% of portfolio
1.95%
Previous 1.44%
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
343Shares Held
141MCall Options Held
2.25MPut Options Held
3.11M-
Vanguard Group Inc Valley Forge, PA14.5MShares$1.06 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$863 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$787 Million0.04% of portfolio
-
State Street Corp Boston, MA5.91MShares$432 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.78MShares$350 Million4.29% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.9B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...